Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000259676

Medchemexpress LLC 2-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-pyrazolo[1,5-a]pyridine | 337972-47-1 | MFCD06798338 | 99.8% | C18H19ClN4 | 10MG
SDP

Catalog No. 5000259676
Encompass_Preferred

FAUC 213 is an orally active, highly selective dopamine D4 receptor complete antagonist used as a research compound in neuroscience and pharmacology studies. It shows high affinity for the human D4.4 receptor, reduced activity at D2 and D3 receptors, and can cross the blood-brain barrier.

  • High affinity for dopamine D4 receptor (Ki = 2.2 nM for hD4.4).
  • Low activity at D2 and D3 receptors (Ki = 3.4 μM and 5.3 μM, respectively).
  • Orally active and brain penetrant.
  • Useful as a tool to study dopaminergic signaling and atypical antipsychotic profiles.
  • Research use only; not for human or clinical use.

Catalog No. 50-002-59676 Supplier Medchemexpress LLC Supplier No. HY1432710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

FAUC 213 is an orally active, highly selective dopamine D4 receptor complete antagonist used as a research compound in neuroscience and pharmacology studies. It shows high affinity for the human D4.4 receptor, reduced activity at D2 and D3 receptors, and can cross the blood-brain barrier.

  • High affinity for dopamine D4 receptor (Ki = 2.2 nM for hD4.4).
  • Low activity at D2 and D3 receptors (Ki = 3.4 μM and 5.3 μM, respectively).
  • Orally active and brain penetrant.
  • Useful as a tool to study dopaminergic signaling and atypical antipsychotic profiles.
  • Research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.